Cancer research breakthrough
Chulalongkorn University’s research team has reached the first milestone in developing an affordable biologic drug but needs Bt1.33 billion in funding to pursue the remaining phases of the study. Chulalongkorn Cancer Immunotherapy Excellence Centre announced at a press conference yesterday (Oct 24) that its team had made progress in the research to develop immunotherapy treatment for cancer.
Pratch Rujivanarom
